STOCK TITAN

IEH Corp Gets $3.6M in Defibrillator Connector Orders

IEH says the order supports its effort to build a medical-market presence alongside its defense business.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IEH Corporation (IEHC) received $3.6 million in new orders for its Hyperboloid connectors from a leading manufacturer of mobile defibrillators. The company says the medical market is a strategic growth priority and the orders complement its record defense backlog, alongside recent defense orders supporting the PATRIOT and APKWS missile programs.

The connectors use angled wires around a mating pin to create multiple contact lines. IEH says the design resists shock and vibration and supports an exceptionally high number of mating cycles with low insertion force.

Positive

  • None.

Negative

  • None.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Orders for mobile defibrillator applications $3.6 million New orders for Hyperboloid connectors
Operating history 85 years Company history described in the About IEH section
Family-run management Four generations Management history described in the About IEH section
Founded 1941 Company founding year
Hyperboloid contact design technical
"IEH's Hyperboloid contact design wraps a sleeve of angled wires around the mating pin"
printed circuit board (PCB) connectors technical
"designed, developed and manufactured printed circuit board (PCB) connectors"
mating cycles technical
"an exceptionally high number of mating cycles with low insertion force"
insertion force technical
"mating cycles with low insertion force"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much in defibrillator orders did IEHC receive?

IEH Corporation received $3.6 million in new orders for Hyperboloid connectors from a leading manufacturer of mobile defibrillators.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0000050292 0000050292 2026-09-24 2026-09-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 24, 2026

 

 IEH Corporation

(Exact Name of Registrant as Specified in Charter)  

 

New York   0-5278   13-5549348
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

140 58th Street, Suite 8E

Brooklyn, NY 11220

(Address of Principal Executive Offices, and Zip Code)

 

(718) 492-4440 

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report) 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock  IEHC OTC QX

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1 

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibit is attached to this Current Report on Form 8-K:

     
Exhibit Number   Exhibit Title or Description
     
99.1   Press Release issued September 24, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

 

 

2 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

    IEH Corporation
     
    By:  /s/Subrata Purkayastha
    Name: Subrata Purkayastha
    Title: Chief Financial Officer
Date:   September 25, 2026    

 

 

 

 

3 

 

 

Exhibit 99.1

 

Beyond Defense: IEH Books $3.6 Million in Orders for Lifesaving Defibrillator Applications

 

The orders mark a significant step in IEH's expansion into the medical market, complementing the Company's record defense backlog

 

BROOKLYN, N.Y., September 24, 2026 – When a defibrillator is called on to restart a heart, every connection inside it has to work the first time. That is why a leading manufacturer of mobile defibrillators has selected Hyperboloid connectors from IEH Corporation (OTCQX: IEHC), placing $3.6 million in new orders with the Company.

 

The award stands apart from IEH's recent string of defense orders, including those supporting the PATRIOT and APKWS missile programs. It comes from the medical sector, a market the Company has identified as a strategic growth priority.

 

Mobile defibrillators are carried in ambulances, mounted in public spaces and deployed in unpredictable conditions. They face shock, vibration and repeated handling, yet must perform flawlessly in an emergency. IEH's Hyperboloid contact design wraps a sleeve of angled wires around the mating pin, creating multiple continuous lines of contact. The result is a connection that resists shock and vibration, maintains low electrical resistance, and holds up through an exceptionally high number of mating cycles with low insertion force. These are the same attributes that have made Hyperboloid technology the standard in myriad defense, aerospace and space applications.

 

Dave Offerman, President and CEO of IEH Corporation, commented, "For decades, our Hyperboloid connectors have been trusted in applications where failure is not an option. A defibrillator is exactly that kind of application, with a different mission: saving a life in the moments that matter most. We're proud that a leading medical device maker chose IEH for that reason. This order is an important proof point as we build our presence in the medical market, which gives IEH a meaningful source of growth alongside our defense business."

 

About IEH Corporation

 

For 85 years and four generations of family-run management, IEH Corporation has designed, developed and manufactured printed circuit board (PCB) connectors, custom interconnects and contacts for high-performance applications. With its signature Hyperboloid technology, IEH supplies the most durable, reliable connectors for the most demanding environments. The Company serves customers in the defense, aerospace, space, medical and industrial markets in the United States, Canada, Europe, Southeast and Central Asia and the Mideast. The Company was founded in 1941 and is headquartered in Brooklyn, New York.

 

 

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Certain statements contained in this press release, and in related comments by the Company’s management, include “forward-looking statements.” All statements, other than statements of historical facts, including, without limitation, statements or expectations regarding our financial condition, statements or expectations regarding our revenues, cash and backlog, expectations regarding future cash requirements, revenue and revenue recovery, including for fiscal year 2027 and beyond, projected timelines for making our SEC filings or successfully preventing our registration from suspension or revocation and expectations regarding our efforts and ability to resolve our inventory accounting issues are forward-looking statements. These statements often include words such as “believe,” “expect,” “estimate,” “plan,” “will,” “may,” “would,” “should,” “could,” or similar expressions, although not all forward-looking statements contain such identifying words. These statements are based on certain assumptions that the Company has made on its current expectations and projections about future events. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and you should not place undue reliance on any forward-looking statements. The Company’s actual performance or results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, as they will depend on many factors about which we are unsure, including many factors beyond our control. Among other items, such factors could include: any claims, investigations or proceedings arising as a result of our past due periodic reports, including changes in the proceedings related to the SEC’s Order Instituting Administrative Proceedings and Notice of Hearing pursuant to Section 12(j) of the Securities and Exchange Act of 1934, as amended; our ability to remediate our inventory accounting issue; our ability to reduce costs or increase revenue; changes in the macroeconomic environment or in the finances of our customers; changes in accounting principles, or their application or interpretation, and our ability to make accurate estimates and the assumptions underlying the estimates; our ability to attract and retain key employees and key resources; and other risk factors discussed from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on June 12, 2026, and in subsequent reports filed with or furnished to the SEC. Additional information concerning these and other factors can be found in our filings with the SEC. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. Except as may be required by applicable law, we do not undertake or intend to update or revise our forward-looking statements, and we assume no obligation to update any forward-looking statements contained in this press release as a result of new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should carefully review and consider the various disclosures we make in our filings with the SEC that attempt to advise interested parties of the risks, uncertainties and other factors that may affect our business.

 

Contact:

 

Dave Offerman

 

IEH Corporation

 

dave@iehcorp.com

 

718-492-4448

 

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading